ArticleCancer immunology, immunotherapy : CII2021

Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.

Junyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.